cyc 202 has been researched along with concanavalin a in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 17,959 | 82 | 1,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiello, S; Azzollini, N; Benigni, A; Cassis, L; Mister, M; Monteferrante, G; Noris, M; Pezzotta, A; Remuzzi, G; Satta, M | 1 |
1 other study(ies) available for cyc 202 and concanavalin a
| Article | Year |
|---|---|
Effect of seliciclib (CYC202, R-roscovitine) on lymphocyte alloreactivity and acute kidney allograft rejection in rat.
Topics: Animals; Cell Division; Cell Survival; Coculture Techniques; Concanavalin A; Flow Cytometry; Graft Rejection; Graft Survival; Kidney Transplantation; Lymph Nodes; Lymphocyte Culture Test, Mixed; Male; Protein Kinase Inhibitors; Purines; Rats; Rats, Inbred BN; Rats, Inbred WF; Roscovitine; Transplantation, Homologous | 2008 |